At-Risk Groups Underrepresented in Cancer Trials Leading to Approvals

(MedPage Today) -- At-risk populations -- particularly Black and Hispanic patients -- are significantly underrepresented in pivotal clinical trials for leukemias and multiple myeloma, a recent analysis showed. Among 41 trials that led to FDA...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news